Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
808 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02321631 | Efficacy of EPA-enriched Supplement in Malnourished Head and Neck Cancer Patients Undergone Surgery | completed | N/A | 70 | Prince of Songkla UniversityOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT02879968 | Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer | completed | — | 52 | Prince of Songkla UniversityOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03825146 | The Effects of AMPC in the Treatments of Refractory or Relapsed AML(AMPCAL) | unknown | Phase 1 | 10 | Lai Corporation Pty. Ltd.INDUSTRY | 1 | Feb 24, 2020 | clinicaltrials |
| NCT03315195 | Preoperative Oral Nutritional Supplement vs Conventional Dietary Advice in Major Gastrointestinal Surgery | unknown | N/A | 268 | Mahidol UniversityOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03818633 | Elastic Abdominal Binder Following Gynecologic Cancer Surgery | completed | N/A | 109 | Chiang Mai UniversityOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT01998542 | Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck(HNC) | completed | Phase 2 | 12 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 23, 2020 | clinicaltrials |
| NCT02674243 | Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion | completed | Phase 3 | 60 | Chiang Mai UniversityOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT01741038 | AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02409524 | An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects | completed | Phase 2 | 15 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02624999 | Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck | withdrawn | Phase 2 | 0 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT01591122 | Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer | completed | Phase 3 | 313 | Janssen Research & Development, LLCINDUSTRY | 4 | Jan 21, 2020 | clinicaltrials |
| NCT03669107 | Effect of Chewing Gum on Gastrointestinal Function Recovery After Surgery of Gynecological Cancer Patients | completed | N/A | 80 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Jan 14, 2020 | clinicaltrials |
| NCT02272413 | Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer | completed | Phase 3 | 671 | Boehringer IngelheimINDUSTRY | 28 | Jan 13, 2020 | clinicaltrials |
| NCT00294047 | Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older | completed | Phase 3 | 5,752 | GlaxoSmithKlineINDUSTRY | 12 | Jan 2, 2020 | clinicaltrials |
| NCT02465528 | Ceritinib Rare Indications Study in ALK+ Tumors | terminated | Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 27, 2019 | clinicaltrials |
| NCT02008227 | A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy(OAK) | completed | Phase 3 | 1,225 | Hoffmann-La RocheINDUSTRY | 31 | Dec 20, 2019 | clinicaltrials |
| NCT02066961 | A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer(ASPIRE-PCa) | completed | — | 1,533 | Astellas Pharma Global Development, Inc.INDUSTRY | 27 | Dec 20, 2019 | clinicaltrials |
| NCT00567190 | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer(CLEOPATRA) | completed | Phase 3 | 808 | Genentech, Inc.INDUSTRY | 26 | Dec 13, 2019 | clinicaltrials |
| NCT00908752 | Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC(BRISK TA) | completed | Phase 3 | 734 | Bristol-Myers SquibbINDUSTRY | 13 | Dec 2, 2019 | clinicaltrials |
| NCT01844375 | A Trial of Preoperative CHO Drinks on Postoperative Walking Capacity in Colorectal Surgery | completed | N/A | 70 | Mingkwan Wongyingsinn, MDOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT00937950 | Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects | completed | Phase 3 | 2,022 | GlaxoSmithKlineINDUSTRY | 13 | Oct 29, 2019 | clinicaltrials |
| NCT01905943 | A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia | completed | Phase 3 | 979 | Hoffmann-La RocheINDUSTRY | 31 | Oct 28, 2019 | clinicaltrials |
| NCT02783794 | BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Meabco A/SINDUSTRY | 2 | Oct 10, 2019 | clinicaltrials |
| NCT03789019 | BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment | completed | Phase 2 | 29 | Meabco A/SINDUSTRY | 2 | Oct 10, 2019 | clinicaltrials |
| NCT01861509 | BP-C1 in Metastatic Breast Cancer Patients | completed | Phase 1 | 10 | Meabco A/SINDUSTRY | 2 | Oct 7, 2019 | clinicaltrials |
| NCT03603197 | BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer | completed | Phase 2 | 38 | Meabco A/SINDUSTRY | 1 | Oct 7, 2019 | clinicaltrials |
| NCT01004224 | A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies | completed | Phase 1 | 208 | Novartis PharmaceuticalsINDUSTRY | 14 | Oct 4, 2019 | clinicaltrials |
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma | completed | Phase 3 | 355 | Eli Lilly and CompanyINDUSTRY | 30 | Sep 25, 2019 | clinicaltrials |
| NCT02187367 | Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients(EGF) | terminated | Phase 3 | 106 | Bioven EuropeINDUSTRY | 11 | Sep 10, 2019 | clinicaltrials |
| NCT02765503 | Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial(HYPNO) | unknown | N/A | 836 | International Atomic Energy AgencyOTHER_GOV | 9 | Aug 8, 2019 | clinicaltrials |
| NCT02292446 | Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available. | completed | Phase 3 | 161 | Novartis PharmaceuticalsINDUSTRY | 12 | Jul 18, 2019 | clinicaltrials |
| NCT01792726 | A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.(TARGIT-B) | unknown | N/A | 1,796 | University College, LondonOTHER | 12 | Jul 12, 2019 | clinicaltrials |
| NCT02281019 | SpyGlass AMEA Registry | completed | — | 526 | Boston Scientific CorporationINDUSTRY | 10 | Jul 10, 2019 | clinicaltrials |
| NCT01892345 | A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) | terminated | Phase 3 | 143 | Alexion Pharmaceuticals, Inc.INDUSTRY | 18 | Jun 26, 2019 | clinicaltrials |
| NCT01206764 | A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. | completed | Phase 4 | 143 | Novartis PharmaceuticalsINDUSTRY | 10 | Jun 24, 2019 | clinicaltrials |
| NCT03890354 | Robot-Assisted or Laparoscopic Resection for Gastric Subepithelial Tumor With Hand-Sewn Repair, a Case Series | completed | — | 27 | Mahidol UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT01287741 | A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) | terminated | Phase 3 | 1,418 | Hoffmann-La RocheINDUSTRY | 29 | Apr 12, 2019 | clinicaltrials |
| NCT00820222 | Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer | completed | Phase 3 | 540 | Novartis PharmaceuticalsINDUSTRY | 14 | Apr 2, 2019 | clinicaltrials |
| NCT01685138 | LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer | completed | Phase 2 | 124 | Novartis PharmaceuticalsINDUSTRY | 18 | Mar 26, 2019 | clinicaltrials |
| NCT02117479 | Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) | terminated | Phase 3 | 321 | Incyte CorporationINDUSTRY | 12 | Mar 26, 2019 | clinicaltrials |
| NCT03778710 | Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection | completed | — | 155 | Mahidol UniversityOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT02271646 | Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation | completed | N/A | 35 | Mahidol UniversityOTHER | 1 | Mar 12, 2019 | clinicaltrials |
| NCT01243944 | Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) | completed | Phase 3 | 222 | Incyte CorporationINDUSTRY | 18 | Mar 6, 2019 | clinicaltrials |
| NCT01561586 | Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer(TACO) | unknown | Phase 3 | 374 | Korea Cancer Center HospitalOTHER | 4 | Feb 27, 2019 | clinicaltrials |
| NCT03059732 | Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan | completed | — | 700 | King Chulalongkorn Memorial HospitalOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03035825 | Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients | completed | N/A | 73 | Dental Innovation Foundation Under Royal PatronageOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT02364999 | A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC | completed | Phase 3 | 719 | PfizerINDUSTRY | 27 | Feb 7, 2019 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials